Charles S. Fuchs, director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital, has been named senior vice president and global head of product development for oncology and hematology at Roche and Genentech.
Crystal S. Denlinger was named to the new role of senior vice president and chief scientific officer of National Comprehensive Cancer Network.
Jonathan Weinbach was named chief executive officer of the New York Proton Center.
Christian Hinrichs was named chief of the Section of Cancer Immunotherapy and co-director of the Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute of New Jersey.
Kenneth H. Kim was selected to direct the Division of Gynecologic Oncology at Cedars-Sinai Cancer. He is also chair of the cancer center's Committee for Oversight of Training and Education.
Sonali M. Smith, an expert in the treatment of lymphoma, was named chief of the Section of Hematology/Oncology at the University of Chicago Medicine and the UChicago Medicine Comprehensive Cancer Center.
The Tisch Cancer Institute at Mount Sinai has been awarded a $1.9 million grant by NCI for a study that will explore the mechanisms that enable tumor cells to spread from their original site but remain dormant for some time before becoming metastatic and threatening the lives of patients.
Joshua E. Meyer, associate professor in the Department of Radiation Oncology at Fox Chase Cancer Center, has received a $422,368 grant to investigate the role of local consolidative therapy with radiation in the second-line treatment of metastatic colorectal cancer.
Memorial Sloan Kettering Cancer Center has launched a podcast, “Cancer Straight Talk from MSK,” led by Diane Reidy-Lagunes and colleagues.
A new law has given FDA the authority to update the approved labeling on generics—including for many older cancer drugs.
